Form 4: Trulieve Director Peter Healy Granted RSUs

Trulieve Cannabis Corp. Director Peter Healy received a grant of 18,610 restricted stock units, increasing his beneficial ownership to 49,235 shares.

Summary

• Peter Healy, a Director of Trulieve Cannabis Corp. (TRUL), was granted 18,610 restricted stock units (RSUs) on August 12, 2025.
• Each RSU represents a contingent right to receive one Trulieve subordinate voting share.
• The RSUs were granted at a price of $0.
• Following this transaction, Peter Healy beneficially owns a total of 49,235 subordinate voting shares directly.
• The RSUs will vest on the earliest of the end of Mr. Healy's service on the board, a change of control of Trulieve, or December 1, 2031.

Sentiment

Score: 7

Explanation: The grant of restricted stock units to a director is a positive sign of aligning management incentives with shareholder interests, reflecting a standard compensation practice. It's a routine filing with no negative implications.

Positives

• The grant of 18,610 restricted stock units to a director aligns management's interests with shareholder value.
• The grant was at a price of $0, indicating it is a compensation component that incentivizes long-term commitment without requiring an upfront cash outlay from the director.

Risks

• The restricted stock units are subject to vesting conditions, meaning the shares are not immediately owned and could be forfeited if the specified conditions (continued service, change of control, or time) are not met.
• Vesting is tied to continued service on the board, a change of control, or a long-term date (December 1, 2031), introducing future uncertainty regarding the full realization of the shares.

Future Outlook

The restricted stock units are designed to vest upon the earliest of the director's cessation of service, a change of control, or December 1, 2031, aligning the director's long-term interests with the company's performance and stability.

Industry Context

This filing reflects a standard compensation practice (equity grants) for directors in publicly traded companies, including those in the cannabis industry, aiming to align leadership incentives with long-term shareholder value and retention.

Comparison to Industry Standards

• The grant of restricted stock units to a director is a common form of equity compensation across various industries, including the cannabis sector, used by companies like Curaleaf Holdings, Green Thumb Industries, and Cresco Labs to incentivize long-term commitment and performance.
• The vesting schedule tied to service, change of control, or a specific date is a standard mechanism for such grants, comparable to practices seen in other publicly traded companies.

Corporate Governance

Related Party Transactions

• Grant of 18,610 restricted stock units to Peter Healy, a Director of Trulieve Cannabis Corp., as part of his compensation package.

Stakeholder Impact

• Shareholders: Potential positive impact due to increased alignment of the director's interests with long-term company performance and value creation.
• Management/Directors: Direct benefit through equity compensation, incentivizing continued service and performance.

Next Steps

• The restricted stock units will vest upon the earliest of the director's cessation of service on the board, a change of control of Trulieve, or December 1, 2031.

Key Dates

Recommendation

This Form 4 filing details a routine equity compensation grant to a director, which is a standard practice to align management incentives with shareholder interests. It does not contain information that would significantly alter the fundamental outlook or valuation of Trulieve Cannabis Corp., thus a 'hold' recommendation is appropriate as it doesn't present new reasons to buy or sell based solely on this filing.

Keywords

Trulieve, TRUL, SEC Form 4, insider transaction, director compensation, restricted stock units, RSU, cannabis, beneficial ownership